Cresset Asset Management, LLC Qiagen N.V. Transaction History

Cresset Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$35.55 - $43.57 $109,671 - $134,413	3,085 Added 26.33%	14,801 $642,000
Q3 2023 Nov 14, 2023	BUY	$39.13 - $47.24 $12,952 - $15,636	331 Added 2.91%	11,716 $474,000
Q2 2023 Aug 14, 2023	BUY	$43.93 - $46.76 $500,143 - $532,362	11,385 New	11,385 $512,000
Q4 2021 Feb 10, 2022	SELL	$50.62 - $56.47 $270,817 - $302,114	-5,350 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$46.55 - $56.83 $37,053 - $45,236	796 Added 17.48%	5,350 $276,000
Q2 2021 Aug 10, 2021	BUY	$46.28 - $52.75 $210,759 - $240,223	4,554 New	4,554 $220,000
Q2 2019 Aug 12, 2019	SELL	$35.73 - $41.39 $81,607 - $94,534	-2,284 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$33.78 - $40.68 $76,005 - $91,530	2,250 Added 6617.65%	2,284 $93,000
Q4 2018 May 21, 2019	BUY	$32.65 - $37.95 $1,110 - $1,290	34 New	34 $1,000

6.37M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $10.5B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cresset Asset Management, LLC with notifications on news.